THE LANCET - Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

THE LANCET - Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31022-9/fulltext

3 de maio de 2020

Categorias

Categorias

Arquivo de Notícias

Arquivo